Clinical Trial

The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.

Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-center single-arm study. The main purpose of this study is to study the efficacy of surgical treatment for patients with locally advanced cervical cancer (FIGO IB3, IIA2-IVA) who still have residual tumor after concurrent radiotherapy and chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-20.
Trial Details
NCT Number NCT05749887
Lead Sponsor Chongqing University Cancer Hospital
Conditions Cervical Cancer
Enrollment 188 participants
Start Date 2023-08-25
Primary Completion 2027-07-01 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-10